Novartis presents first-of-its-kind histology data with iscalimab

This article was originally published here

“Extending the life of transplanted kidneys would mean fewer patients going back on dialysis or needing a second transplant – relieving pressure on waiting lists that in the

The post Novartis presents first-of-its-kind histology data with iscalimab appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply